Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Pacific Biosciences (PACB)
:PACB
RESEARCH TOOLSreports
Earnings Data
Report Date
May 08, 2025TBA Not Confirmed
Period Ending
2025 (Q1)Consensus EPS Forecast
-0.19Last Year’s EPS
-0.29Same Quarter Last Year
Moderate Buy
Based on 7 Analysts Ratings
---
Earnings Call Summary
Earnings Call Date:Feb 13, 2025
|% Change Since: 19.59%
|Next Earnings Date:May 08, 2025
Earnings Call Sentiment|Neutral
PacBio demonstrated strong growth in genomic data output and consumable revenue, along with successful product launches and cost reductions. However, significant challenges remain, including a substantial decline in instrument revenue, macroeconomic and funding uncertainties, and extended cash flow breakeven timeline due to recent challenges.Company Guidance
During the PacBio Fourth Quarter 2024 Earnings Conference Call, the company provided guidance for 2025, anticipating revenue to range between $155 million and $170 million, reflecting a 6% year-over-year growth at the midpoint. The company reported $39.2 million in revenue for the fourth quarter, driven by the shipment of 23 Brevio systems and seven Vega Benchtop platforms. For the full year, revenue totaled $154 million, with a notable increase in genomic data output, accelerating by 81% in 2024. Consumable revenue grew by 11% to $70.4 million. Looking ahead, the company expects the macroeconomic pressures and NIH funding uncertainties to impact sales cycles but maintains confidence in achieving a 16% compound annual growth rate since 2020. The company also aims to improve non-GAAP gross margins to between 35% and 40% and reduce non-GAAP operating expenses by 3% to 7% in 2025, with plans to turn cash flow positive exiting 2027.Record Revenue Growth in 2024
PacBio achieved $154 million in revenue for the full year 2024, driven by the shipment of 97 Revio systems. This reflects a notable increase in the customer base, with approximately 45% of Revio shipments going to new customers.
Significant Increase in Genomic Data Output
Total growth in genomic data output accelerated with an 81% increase in 2024, up from 68% in 2023. This increase highlights broader utilization of PacBio's HiFi Longreach sequencing technology.
Consumable Revenue Growth
Consumable revenue grew 11% year over year in 2024 to $70.4 million, representing a 23% compound annual growth rate since 2020.
Successful Product Launches
PacBio launched the Vega Benchtop platform and Spark Chemistry for Revio, offering a suite of long-range sequencing systems tailored to different customer needs.
Strong Customer Feedback for Vega
Berry Genomics, an early adopter of Vega, reported notable improvements in quality values, reduced run times, and greater data processing efficiency.
Cost Reductions and Financial Flexibility
Annualized non-GAAP operating expenses were reduced by more than $75 million, and convertible note exchange reduced debt by $259 million, strengthening financial flexibility.
---
PACB Earnings History
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
---
PACB Earnings-Related Price Changes
Report Date | Price 1 Day Before | Price 1 Day After | Percentage Change |
|---|---|---|---|
| Feb 13, 2025 | $1.48 | $1.85 | +25.00% |
| Nov 07, 2024 | $2.45 | $2.30 | -6.12% |
| Aug 07, 2024 | $1.53 | $1.67 | +9.15% |
| May 09, 2024 | $1.72 | $1.77 | +2.91% |
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
---
FAQ
When does Pacific Biosciences (PACB) report earnings?
Pacific Biosciences (PACB) is schdueled to report earning on May 08, 2025, TBA Not Confirmed.
What is Pacific Biosciences (PACB) earnings time?
Pacific Biosciences (PACB) earnings time is at May 08, 2025, TBA Not Confirmed.
Where can I see when companies are reporting earnings?
You can see which companies are reporting today on our designated earnings calendar.
What companies are reporting earnings today?
You can see a list of the companies which are reporting today on TipRanks earnings calendar.
What is PACB EPS forecast?
PACB EPS forecast for the fiscal quarter 2025 (Q1) is -0.19.
---